Evaluation of polymeric based desalting cartridge for LC/MS based biopharmaceutical applications

Significance of the Topic

Monoclonal antibodies are a cornerstone of modern therapeutics, requiring precise characterization to ensure safety and efficacy. Liquid chromatography–mass spectrometry (LC/MS) is widely used for detailed profiling, but residual nonvolatile salts and detergents from sample preparation can suppress ionization and degrade spectral quality. Effective online desalting is therefore critical for robust biopharmaceutical analysis.

Objectives and Overview

This study evaluated a novel polymeric reverse-phase desalting cartridge for both one-dimensional (1D) and two-dimensional (2D) LC/MS workflows. The goal was to demonstrate improved mass spectrometric performance for monoclonal antibody (mAb) samples containing varying salt concentrations and to integrate desalting seamlessly into multidimensional separation methods.

Methodology

A polymeric-based AdvanceBio RP desalting cartridge was tested under two main scenarios:

• 1D desalting of reduced mAb samples spiked with 0, 150, and 300 mM NaCl to assess salt removal efficiency.
• 2D LC/MS combining either ion-exchange (IEX) or Protein A affinity capture in the first dimension with on-line desalting in the second dimension using heart-cutting intervals.
• Operating parameters included gradient elution programs, flow rates (0.4–1.0 mL/min), and precise timing for multiple heart cuts (0.04 min segments).

Used Instrumentation

• Agilent Bio MAb NP5 ion-exchange column (4.6 × 250 mm)
• Agilent Bio-Monolith Protein A affinity column
• AdvanceBio RP desalting cartridges (2.1 × 12.5 mm, 10 μm, 1000 Å)
• Binary and quaternary high-pressure LC pumps with autosampler (5 μL injection)
• UV detector set at 280 nm
• QTOF mass spectrometer equipped with electrospray ionization (gas temp 350 °C, sheath gas 400 °C)

Results and Discussion

The polymeric desalting cartridge delivered up to a sixfold increase in MS signal intensity compared to workflows without on-line desalting. Salt concentrations up to 300 mM had minimal impact on glycoform quantification of Herceptin heavy chains. Multidimensional heart-cutting effectively isolated target proteoforms and removed contaminants prior to MS analysis.

• Consistent desalting performance across multiple injections demonstrated high reproducibility.
• 1D experiments confirmed complete removal of nonvolatile salts and detergents, restoring baseline ionization.
• 2D LC/MS workflows maintained chromatographic resolution and enabled automated sample cleanup in a single run.

Benefits and Practical Applications

• Enhanced sensitivity and spectral clarity for mAb heterogeneity profiling.
• Reduced manual sample handling and risk of contamination.
• Seamless integration into existing 1D and 2D LC/MS methods for biopharmaceutical QA/QC.

Future Trends and Opportunities

Integration of polymeric desalting cartridges with high-throughput, automated platforms will streamline biopharmaceutical workflows. Future developments may focus on miniaturized cartridge formats, compatibility with next-generation mass analyzers, and expanded applications to other protein therapeutics and complex biologics.

Conclusions

The AdvanceBio RP polymeric desalting cartridge effectively removes salts and detergents from mAb samples, significantly enhancing LC/MS sensitivity and reproducibility. Its implementation in 1D and multidimensional workflows offers a robust solution for biopharmaceutical characterization.